p2x7 rna expression data Search Results


92
Santa Cruz Biotechnology sirna transfection cells
Sirna Transfection Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/P2X7+siRNA/10__1158_slash_1541___7786__mcr___16___0373-167-11-21
Average 92 stars, based on 1 article reviews
sirna transfection cells - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

86
Human Protein Atlas p2x7 rna expression data
P2x7 Rna Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/data+rna+seq/pmc13172163-145-0-15
Average 86 stars, based on 1 article reviews
p2x7 rna expression data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Pfizer Inc p2x7-r variant 1 mrna
P2x7 R Variant 1 Mrna, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/p2x7+ko+mice/pmc03254638-150-12-25
Average 90 stars, based on 1 article reviews
p2x7-r variant 1 mrna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Alomone Labs apr 004 caspase 1 mouse
FIGURE 3. P2X7 activation on microglia led to microglial pyroptosis. (A) qPCR analysis for inflammatory-related genes (GSDMD, <t>caspase-1,</t> and NLRP3) in RD retinas at each observed time point (n = 4). (B) Western blot analysis for NLRP3 and NF-κB p-p65 protein expression (NLRP3, n = 3; NF-κB p-p65, n = 5). (C) Western blot analysis for GSDMD-FL and cleaved-GSDMD at each observed time point (GSDMD-FL, cleaved-GSDMD: n = 6). (D) Heatmap of GSDMD, IL-1β, and caspase-1 from RNA sequencing of naïve and detached retina. (Naïve, n = 3; 2 days after RD, n = 5.) (E) Representative images from cross-sections stained with Iba-1 and caspase-1/IL-1β/GSDMD/NF-κB at 3 days after RD (n = 4). Representative cells of colocalization were marked by white arrows (caspase-1), yellow arrows (IL-1β), blue arrows (GSDMD), and red arrows (NF-κB p-p65), respectively. (F) Representative immunofluorescent images of TUNEL+ cells in ONL of naïve and retinas 4 days after RD (naïve, n = 3; 3 days after RD, n = 3). (E, F) Scale bars, 50 μm. Z-stack images of the entire thickness of the retina were created. Nuclei staining: DAPI. Statistical analysis: (A, B, C) one-way ANOVA followed by Dunnett’s multiple comparison. *P < 0.05, **P < 0.01, ****P < 0.0001.
Apr 004 Caspase 1 Mouse, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/Anti-P2X7+Receptor+Antibody/pm37351878-50-24-22
Average 96 stars, based on 1 article reviews
apr 004 caspase 1 mouse - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology p2x7 short hairpin
A, images of representative astrocytes double‐labelled with antibodies against GFAP (red) and <t>P2X7</t> receptors (green). Scale bar = 20 μm. B, BBG (100 nm), a specific P2X7 receptor antagonist, inhibited MARA in astrocytes. Inset: BBG (100 nm) did not affect the sensitivity of ATP sniffer currents (n = 6). C, summary of the effect of BBG on evoked ATP release (n = 6). ** P < 0.01. D, immunofluorescence staining showing partial knockdown of P2X7 receptors. Scale bar = 20 μm. E, upper, western blots showing partial knockdown of P2X7 receptors by RNAi. Lower: normalized P2X7 protein levels were 100% (control), 93 ± 9% (scrambled) and 39 ± 13% (RNAi) (n = 9). ** P < 0.01. F, MARA was markedly lower in P2X7 knockdown astrocytes than in normal astrocytes, or scrambled RNAi‐transfected astrocytes. G, summary of the RNAi knockdown effect on MARA (n = 20). *** P < 0.001.
P2x7 Short Hairpin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/P2X7+Lentiviral+Activation+Particles/pmc05978314-217-0-11
Average 91 stars, based on 1 article reviews
p2x7 short hairpin - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
Synthego Inc single guide (sg) rna1
A, images of representative astrocytes double‐labelled with antibodies against GFAP (red) and <t>P2X7</t> receptors (green). Scale bar = 20 μm. B, BBG (100 nm), a specific P2X7 receptor antagonist, inhibited MARA in astrocytes. Inset: BBG (100 nm) did not affect the sensitivity of ATP sniffer currents (n = 6). C, summary of the effect of BBG on evoked ATP release (n = 6). ** P < 0.01. D, immunofluorescence staining showing partial knockdown of P2X7 receptors. Scale bar = 20 μm. E, upper, western blots showing partial knockdown of P2X7 receptors by RNAi. Lower: normalized P2X7 protein levels were 100% (control), 93 ± 9% (scrambled) and 39 ± 13% (RNAi) (n = 9). ** P < 0.01. F, MARA was markedly lower in P2X7 knockdown astrocytes than in normal astrocytes, or scrambled RNAi‐transfected astrocytes. G, summary of the RNAi knockdown effect on MARA (n = 20). *** P < 0.001.
Single Guide (Sg) Rna1, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/sgrna1/pmc08026201-99-0-7
Average 90 stars, based on 1 article reviews
single guide (sg) rna1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
PromoCell p2x 7 r rna
A, images of representative astrocytes double‐labelled with antibodies against GFAP (red) and <t>P2X7</t> receptors (green). Scale bar = 20 μm. B, BBG (100 nm), a specific P2X7 receptor antagonist, inhibited MARA in astrocytes. Inset: BBG (100 nm) did not affect the sensitivity of ATP sniffer currents (n = 6). C, summary of the effect of BBG on evoked ATP release (n = 6). ** P < 0.01. D, immunofluorescence staining showing partial knockdown of P2X7 receptors. Scale bar = 20 μm. E, upper, western blots showing partial knockdown of P2X7 receptors by RNAi. Lower: normalized P2X7 protein levels were 100% (control), 93 ± 9% (scrambled) and 39 ± 13% (RNAi) (n = 9). ** P < 0.01. F, MARA was markedly lower in P2X7 knockdown astrocytes than in normal astrocytes, or scrambled RNAi‐transfected astrocytes. G, summary of the RNAi knockdown effect on MARA (n = 20). *** P < 0.001.
P2x 7 R Rna, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/Human+Osteoblasts/pmc02837821-195-9-24
Average 96 stars, based on 1 article reviews
p2x 7 r rna - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Proteintech p2x7
Renal denervation reduces NLRP3 inflammasome activation induced by the <t>ATP-P2X7</t> axis. a ATP levels in heart lysates (n = 6). b P2X7 mRNA expression in heart tissue, determined by qRT-PCR (n = 6). c , d Western blot analysis of P2X7, NLRP3 ( c ), ASC, and cleaved-caspase-1 ( d ) in mouse hearts. e Quantification of protein expression levels from ( c , d ) (n = 3). f Immunohistochemical staining of NLRP3 in myocardial sections. g Semi-quantitative scoring of NLRP3 immunoreactivity: 0 (negative), 1 (weak), 2 (mild), 3 (moderate), 4 (strong) (n = 6). h NLRP3 immunofluorescence in H9c2 cardiomyocytes transfected with control siRNA (si-Ctrl) or P2X7 siRNA (si-P2X7) and stimulated with ATP (5 mM). Right panel: relative mean fluorescence intensity (MFI) quantification (n = 6). i , j Western blot of P2X7, NLRP3 ( i ), ASC, and cleaved-caspase-1 ( j ) in H9c2 cells under the same treatments. k Quantification of the protein levels shown in ( i , j ) (n = 3). l Schematic of RNA-seq workflow in neonatal rat ventricular myocytes (NRVMs): Control, ATP, and ATP plus the P2X7 antagonist A438079. m Volcano plot of differentially expressed genes for ATP vs. Control; selected genes related to NLRP3 inflammasome/NF-κB/leukocyte activation are highlighted (FDR-adjusted P shown on the y-axis). n Integrated transcriptomics: Venn diagram showing ATP-induced DEGs reversed by A438079, with a heat map of representative shared genes across groups. One-way ANOVA with Tukey’s post hoc test for ( a, b, e, h and k ); Kruskal–Wallis with Dunn’s post hoc for the ordinal IHC score ( g ). Omics significance was assessed by FDR-adjusted P values (Benjamini-Hochberg). Data are mean ± SD unless noted. * P < 0.05, ** P < 0.01, *** P < 0.001
P2x7, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/P2RX7+Antibody/pmc12680762-105-8-10
Average 95 stars, based on 1 article reviews
p2x7 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Alomone Labs p2x7r extracellular epitope
List of primary antibodies and pharmacological compounds.
P2x7r Extracellular Epitope, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/Anti-P2X7+Receptor+(extracellular)+Antibody/pmc11631223-1-0-10
Average 95 stars, based on 1 article reviews
p2x7r extracellular epitope - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Shanghai Genechem Ltd p2x7 sirna sip2x7
List of primary antibodies and pharmacological compounds.
P2x7 Sirna Sip2x7, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/p2x7+sirna+sip2x7/pm25976617-50-1-7
Average 90 stars, based on 1 article reviews
p2x7 sirna sip2x7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

98
Thermo Fisher gene exp p2rx7 hs00175721 m1
Cathelicidin-Mediated Inhibition of Colon Cancer Cell Migration Was <t>P2RX7</t> Dependent (A) SW620 cells were transfected with control lentivirus or TUBB3-overexpressing lentivirus, followed by exposure to LL-37. Cell migration of SW620 cells. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 siRNA (80 pmol/mL), followed by exposure to LL-37. TUBB3 mRNA expression. (C) CAMP, (D) FPRL1, and (E) P2RX7 mRNA expression in human colon cancer PCR array plate. (F) Cell migration of SW620 cells. SW620 cells were treated with DMSO, KN62, and WRW4 for 30 min, followed by LL-37 for 7 h. Results were pooled from three independent experiments.
Gene Exp P2rx7 Hs00175721 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/Gene+Exp%2E+P2RX7%2C+Hs00175721_m1/pmc06389776-5-3--1
Average 98 stars, based on 1 article reviews
gene exp p2rx7 hs00175721 m1 - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

90
Schmid GmbH mrna encoding p2x7
Cathelicidin-Mediated Inhibition of Colon Cancer Cell Migration Was <t>P2RX7</t> Dependent (A) SW620 cells were transfected with control lentivirus or TUBB3-overexpressing lentivirus, followed by exposure to LL-37. Cell migration of SW620 cells. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 siRNA (80 pmol/mL), followed by exposure to LL-37. TUBB3 mRNA expression. (C) CAMP, (D) FPRL1, and (E) P2RX7 mRNA expression in human colon cancer PCR array plate. (F) Cell migration of SW620 cells. SW620 cells were treated with DMSO, KN62, and WRW4 for 30 min, followed by LL-37 for 7 h. Results were pooled from three independent experiments.
Mrna Encoding P2x7, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p2x7+rna+expression+data/mrna+encoding+p2x7/pm36367953-426-5-14
Average 90 stars, based on 1 article reviews
mrna encoding p2x7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FIGURE 3. P2X7 activation on microglia led to microglial pyroptosis. (A) qPCR analysis for inflammatory-related genes (GSDMD, caspase-1, and NLRP3) in RD retinas at each observed time point (n = 4). (B) Western blot analysis for NLRP3 and NF-κB p-p65 protein expression (NLRP3, n = 3; NF-κB p-p65, n = 5). (C) Western blot analysis for GSDMD-FL and cleaved-GSDMD at each observed time point (GSDMD-FL, cleaved-GSDMD: n = 6). (D) Heatmap of GSDMD, IL-1β, and caspase-1 from RNA sequencing of naïve and detached retina. (Naïve, n = 3; 2 days after RD, n = 5.) (E) Representative images from cross-sections stained with Iba-1 and caspase-1/IL-1β/GSDMD/NF-κB at 3 days after RD (n = 4). Representative cells of colocalization were marked by white arrows (caspase-1), yellow arrows (IL-1β), blue arrows (GSDMD), and red arrows (NF-κB p-p65), respectively. (F) Representative immunofluorescent images of TUNEL+ cells in ONL of naïve and retinas 4 days after RD (naïve, n = 3; 3 days after RD, n = 3). (E, F) Scale bars, 50 μm. Z-stack images of the entire thickness of the retina were created. Nuclei staining: DAPI. Statistical analysis: (A, B, C) one-way ANOVA followed by Dunnett’s multiple comparison. *P < 0.05, **P < 0.01, ****P < 0.0001.

Journal: Investigative ophthalmology & visual science

Article Title: Attenuation of Microglial Activation and Pyroptosis by Inhibition of P2X7 Pathway Promotes Photoreceptor Survival in Experimental Retinal Detachment.

doi: 10.1167/iovs.64.7.34

Figure Lengend Snippet: FIGURE 3. P2X7 activation on microglia led to microglial pyroptosis. (A) qPCR analysis for inflammatory-related genes (GSDMD, caspase-1, and NLRP3) in RD retinas at each observed time point (n = 4). (B) Western blot analysis for NLRP3 and NF-κB p-p65 protein expression (NLRP3, n = 3; NF-κB p-p65, n = 5). (C) Western blot analysis for GSDMD-FL and cleaved-GSDMD at each observed time point (GSDMD-FL, cleaved-GSDMD: n = 6). (D) Heatmap of GSDMD, IL-1β, and caspase-1 from RNA sequencing of naïve and detached retina. (Naïve, n = 3; 2 days after RD, n = 5.) (E) Representative images from cross-sections stained with Iba-1 and caspase-1/IL-1β/GSDMD/NF-κB at 3 days after RD (n = 4). Representative cells of colocalization were marked by white arrows (caspase-1), yellow arrows (IL-1β), blue arrows (GSDMD), and red arrows (NF-κB p-p65), respectively. (F) Representative immunofluorescent images of TUNEL+ cells in ONL of naïve and retinas 4 days after RD (naïve, n = 3; 3 days after RD, n = 3). (E, F) Scale bars, 50 μm. Z-stack images of the entire thickness of the retina were created. Nuclei staining: DAPI. Statistical analysis: (A, B, C) one-way ANOVA followed by Dunnett’s multiple comparison. *P < 0.05, **P < 0.01, ****P < 0.0001.

Article Snippet: CD11b Rat 1:100 (IF) eBioscience 14-0112-82 Iba-1 Goat 1:200 (IF) Novus NB100-1028 Iba-1 Rabbit 1:500 (IF) Abcam ab178846 P2X7 Rabbit 1:200 (IF) Alomone Lab APR-004 Caspase-1 Mouse 1:200 (IF) Santa Cruz sc-56036 IL-1β Mouse 1:100 (IF) Cell Signaling Technology 12242 CD68 Rat 1:100 (IF) eBioscience 14-0681-80 GSDMD Mouse 1:100 (IF) 1:100 (WB) Santa Cruz sc-393656 phospho-NF-κB p65 Rabbit 1:100 (IF) 1:1000 (WB) Cell Signaling Technology 3033S Cryopyrin/NLRP3 Rabbit 1:1000 (WB) Biorbyt orb101128 P2X7 Rabbit 1:100 (IF) 1:200 (WB) MilliporeSigma P8232 GAPDH Rabbit 1:8000 (WB) Abcam ab181603 anti-rabbit IgG HRP Mouse 1:1000 (WB) ROCKLAND 18-8816-33 anti-mouse IgG HRP Rat 1:1000 (WB) ROCKLAND 18-8817-33 HRP, horseradish peroxidase.

Techniques: Activation Assay, Analysis, Western Blot, Expressing, RNA Sequencing, Staining, TUNEL Assay, Comparison, Immunofluorescence

A, images of representative astrocytes double‐labelled with antibodies against GFAP (red) and P2X7 receptors (green). Scale bar = 20 μm. B, BBG (100 nm), a specific P2X7 receptor antagonist, inhibited MARA in astrocytes. Inset: BBG (100 nm) did not affect the sensitivity of ATP sniffer currents (n = 6). C, summary of the effect of BBG on evoked ATP release (n = 6). ** P < 0.01. D, immunofluorescence staining showing partial knockdown of P2X7 receptors. Scale bar = 20 μm. E, upper, western blots showing partial knockdown of P2X7 receptors by RNAi. Lower: normalized P2X7 protein levels were 100% (control), 93 ± 9% (scrambled) and 39 ± 13% (RNAi) (n = 9). ** P < 0.01. F, MARA was markedly lower in P2X7 knockdown astrocytes than in normal astrocytes, or scrambled RNAi‐transfected astrocytes. G, summary of the RNAi knockdown effect on MARA (n = 20). *** P < 0.001.

Journal: The Journal of Physiology

Article Title: Stretch‐induced Ca 2+ independent ATP release in hippocampal astrocytes

doi: 10.1113/JP275805

Figure Lengend Snippet: A, images of representative astrocytes double‐labelled with antibodies against GFAP (red) and P2X7 receptors (green). Scale bar = 20 μm. B, BBG (100 nm), a specific P2X7 receptor antagonist, inhibited MARA in astrocytes. Inset: BBG (100 nm) did not affect the sensitivity of ATP sniffer currents (n = 6). C, summary of the effect of BBG on evoked ATP release (n = 6). ** P < 0.01. D, immunofluorescence staining showing partial knockdown of P2X7 receptors. Scale bar = 20 μm. E, upper, western blots showing partial knockdown of P2X7 receptors by RNAi. Lower: normalized P2X7 protein levels were 100% (control), 93 ± 9% (scrambled) and 39 ± 13% (RNAi) (n = 9). ** P < 0.01. F, MARA was markedly lower in P2X7 knockdown astrocytes than in normal astrocytes, or scrambled RNAi‐transfected astrocytes. G, summary of the RNAi knockdown effect on MARA (n = 20). *** P < 0.001.

Article Snippet: P2X7 short hairpin (sh)RNA(r) and scrambled lentiviral particles were obtained from Santa Cruz Biotechnology.

Techniques: Immunofluorescence, Staining, Knockdown, Western Blot, Control, Transfection

A and B, RT‐PCR for mRNA of P2X7 receptors and pannexin‐1 in cultured astrocytes (A) and C6 cells (B). C, comparison of two normalized typical MARA recordings in an astrocyte (grey trace) and a pannexin‐1‐null glioma C6 cell (black trace). D, statistical comparisons of half‐widths and rise‐times of cultured astrocytes (n = 78) and C6 cells (n = 12).

Journal: The Journal of Physiology

Article Title: Stretch‐induced Ca 2+ independent ATP release in hippocampal astrocytes

doi: 10.1113/JP275805

Figure Lengend Snippet: A and B, RT‐PCR for mRNA of P2X7 receptors and pannexin‐1 in cultured astrocytes (A) and C6 cells (B). C, comparison of two normalized typical MARA recordings in an astrocyte (grey trace) and a pannexin‐1‐null glioma C6 cell (black trace). D, statistical comparisons of half‐widths and rise‐times of cultured astrocytes (n = 78) and C6 cells (n = 12).

Article Snippet: P2X7 short hairpin (sh)RNA(r) and scrambled lentiviral particles were obtained from Santa Cruz Biotechnology.

Techniques: Reverse Transcription Polymerase Chain Reaction, Cell Culture, Comparison

A, expression of P2X7 channels in astrocytes in hippocampal slices. Upper: hippocampal slice from a P2X7‐EGFP transgenic mouse immunostained for GFAP (red) to identify astrocytes; the nuclei were stained with DAPI (blue). Scale bar = 250 μm. Middle: magnified image of boxed area in upper panel. Scale bar = 50 μm. Lower: magnified view of boxed area in middle panel reveals that P2X7 and GFAP co‐localized in astrocytes. Scale bar = 10 μm. B, hippocampal slice from a P2X7‐EGFP transgenic mouse loaded with Fluo4 (10 μm, white) and SR101 (0.5 μm, red). C, left: ATP‐induced Ca2+ elevation in a P2X7‐positive astrocyte was blocked by BBG (200 nm). Right: summary of the BBG effect in P2X7‐positive astrocytes (n = 15). D, left: ATP‐induced Ca2+ elevation in a P2X7‐negative cell was not blocked by BBG (200 nm). Right: summary of the BBG effect in P2X7‐negative cells (n = 6).

Journal: The Journal of Physiology

Article Title: Stretch‐induced Ca 2+ independent ATP release in hippocampal astrocytes

doi: 10.1113/JP275805

Figure Lengend Snippet: A, expression of P2X7 channels in astrocytes in hippocampal slices. Upper: hippocampal slice from a P2X7‐EGFP transgenic mouse immunostained for GFAP (red) to identify astrocytes; the nuclei were stained with DAPI (blue). Scale bar = 250 μm. Middle: magnified image of boxed area in upper panel. Scale bar = 50 μm. Lower: magnified view of boxed area in middle panel reveals that P2X7 and GFAP co‐localized in astrocytes. Scale bar = 10 μm. B, hippocampal slice from a P2X7‐EGFP transgenic mouse loaded with Fluo4 (10 μm, white) and SR101 (0.5 μm, red). C, left: ATP‐induced Ca2+ elevation in a P2X7‐positive astrocyte was blocked by BBG (200 nm). Right: summary of the BBG effect in P2X7‐positive astrocytes (n = 15). D, left: ATP‐induced Ca2+ elevation in a P2X7‐negative cell was not blocked by BBG (200 nm). Right: summary of the BBG effect in P2X7‐negative cells (n = 6).

Article Snippet: P2X7 short hairpin (sh)RNA(r) and scrambled lentiviral particles were obtained from Santa Cruz Biotechnology.

Techniques: Expressing, Transgenic Assay, Staining

Renal denervation reduces NLRP3 inflammasome activation induced by the ATP-P2X7 axis. a ATP levels in heart lysates (n = 6). b P2X7 mRNA expression in heart tissue, determined by qRT-PCR (n = 6). c , d Western blot analysis of P2X7, NLRP3 ( c ), ASC, and cleaved-caspase-1 ( d ) in mouse hearts. e Quantification of protein expression levels from ( c , d ) (n = 3). f Immunohistochemical staining of NLRP3 in myocardial sections. g Semi-quantitative scoring of NLRP3 immunoreactivity: 0 (negative), 1 (weak), 2 (mild), 3 (moderate), 4 (strong) (n = 6). h NLRP3 immunofluorescence in H9c2 cardiomyocytes transfected with control siRNA (si-Ctrl) or P2X7 siRNA (si-P2X7) and stimulated with ATP (5 mM). Right panel: relative mean fluorescence intensity (MFI) quantification (n = 6). i , j Western blot of P2X7, NLRP3 ( i ), ASC, and cleaved-caspase-1 ( j ) in H9c2 cells under the same treatments. k Quantification of the protein levels shown in ( i , j ) (n = 3). l Schematic of RNA-seq workflow in neonatal rat ventricular myocytes (NRVMs): Control, ATP, and ATP plus the P2X7 antagonist A438079. m Volcano plot of differentially expressed genes for ATP vs. Control; selected genes related to NLRP3 inflammasome/NF-κB/leukocyte activation are highlighted (FDR-adjusted P shown on the y-axis). n Integrated transcriptomics: Venn diagram showing ATP-induced DEGs reversed by A438079, with a heat map of representative shared genes across groups. One-way ANOVA with Tukey’s post hoc test for ( a, b, e, h and k ); Kruskal–Wallis with Dunn’s post hoc for the ordinal IHC score ( g ). Omics significance was assessed by FDR-adjusted P values (Benjamini-Hochberg). Data are mean ± SD unless noted. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Basic Research in Cardiology

Article Title: Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis

doi: 10.1007/s00395-025-01138-5

Figure Lengend Snippet: Renal denervation reduces NLRP3 inflammasome activation induced by the ATP-P2X7 axis. a ATP levels in heart lysates (n = 6). b P2X7 mRNA expression in heart tissue, determined by qRT-PCR (n = 6). c , d Western blot analysis of P2X7, NLRP3 ( c ), ASC, and cleaved-caspase-1 ( d ) in mouse hearts. e Quantification of protein expression levels from ( c , d ) (n = 3). f Immunohistochemical staining of NLRP3 in myocardial sections. g Semi-quantitative scoring of NLRP3 immunoreactivity: 0 (negative), 1 (weak), 2 (mild), 3 (moderate), 4 (strong) (n = 6). h NLRP3 immunofluorescence in H9c2 cardiomyocytes transfected with control siRNA (si-Ctrl) or P2X7 siRNA (si-P2X7) and stimulated with ATP (5 mM). Right panel: relative mean fluorescence intensity (MFI) quantification (n = 6). i , j Western blot of P2X7, NLRP3 ( i ), ASC, and cleaved-caspase-1 ( j ) in H9c2 cells under the same treatments. k Quantification of the protein levels shown in ( i , j ) (n = 3). l Schematic of RNA-seq workflow in neonatal rat ventricular myocytes (NRVMs): Control, ATP, and ATP plus the P2X7 antagonist A438079. m Volcano plot of differentially expressed genes for ATP vs. Control; selected genes related to NLRP3 inflammasome/NF-κB/leukocyte activation are highlighted (FDR-adjusted P shown on the y-axis). n Integrated transcriptomics: Venn diagram showing ATP-induced DEGs reversed by A438079, with a heat map of representative shared genes across groups. One-way ANOVA with Tukey’s post hoc test for ( a, b, e, h and k ); Kruskal–Wallis with Dunn’s post hoc for the ordinal IHC score ( g ). Omics significance was assessed by FDR-adjusted P values (Benjamini-Hochberg). Data are mean ± SD unless noted. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: Proteins were detected with the following primary antibodies: P2X7 (11144–1-AP, Proteintech, Rosemont, IL, USA); NLRP3 (30109–1-AP, Proteintech, Rosemont, IL, USA); apoptosis-associated speck-like protein containing a CARD (ASC) (30641–1-AP, Proteintech, Rosemont, IL, USA); Cleaved-Caspase1 (89332, Cell Signaling Technology, Danvers, MA, USA); Caspase1 (83383, Cell Signaling Technology, Danvers, MA, USA); catalase (CAT) (21260–1-AP, Proteintech, Rosemont, IL, USA); glutathione peroxidase 4 (GPX4) (67763–1-Ig, Proteintech, Rosemont, IL, USA); superoxide dismutase 2, mitochondrial (SOD2) (24127–1-AP, Proteintech, Rosemont, IL, USA).

Techniques: Activation Assay, Expressing, Quantitative RT-PCR, Western Blot, Immunohistochemical staining, Staining, Immunofluorescence, Transfection, Control, Fluorescence, RNA Sequencing

Pharmacologic and genetic inhibition of P2X7 mitigates ATP-evoked mitochondrial ROS, oxidative stress, and pyroptosis in vitro. Neonatal Sprague–Dawley rat cardiomyocytes (NRCMs) were pre-treated with the P2X7 antagonist A-438079 (10 µM, 1 h) and then challenged with ATP (5 mM) for 24 h; vehicle was 0.1% DMSO. An A-438079-alone group was included. H9c2 cardiomyocytes were transfected with control siRNA or P2rx7 (P2X7) siRNA and stimulated with ATP (5 mM, 24 h). a MitoTracker staining showing mitochondrial networks under the indicated NRCM treatments. b, c Quantification of mitochondrial network metrics in NRCMs: footprint (µm 2 ) ( b ) and individuals ( c ). d Representative MitoSOX staining (with DAPI) visualizing mitochondrial superoxide in NRCMs. e MitoSOX mean fluorescence intensity (MFI) in NRCMs (n = 6). f Representative DCFH-DA fluorescence images of intracellular ROS (green) with DAPI nuclear counterstain (blue) in H9c2 cardiomyocytes. g Quantification of DCFH-DA mean fluorescence intensity in H9c2 cardiomyocytes (MFI, fold to Control) (n = 3). h-j Oxidative-stress markers in NRCMs: 4-hydroxynonenal (4-HNE) ( h ), 8-OHdG ( i ), catalase (CAT) ( j ) (n = 4). l Western blots of key antioxidant enzymes (CAT, GPX4, SOD2) in H9c2 cells under siRNA treatments. l – o Cytotoxicity/pyroptosis readouts in NRCMs subjected to the pharmacologic protocol: LDH release ( l ), caspase-1 activity ( m ), and IL-1β ( n ) and IL-18 ( o ) in supernatants (n = 4). One-way ANOVA with Tukey’s post hoc was performed for statistical analysis. Data is presented as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Basic Research in Cardiology

Article Title: Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis

doi: 10.1007/s00395-025-01138-5

Figure Lengend Snippet: Pharmacologic and genetic inhibition of P2X7 mitigates ATP-evoked mitochondrial ROS, oxidative stress, and pyroptosis in vitro. Neonatal Sprague–Dawley rat cardiomyocytes (NRCMs) were pre-treated with the P2X7 antagonist A-438079 (10 µM, 1 h) and then challenged with ATP (5 mM) for 24 h; vehicle was 0.1% DMSO. An A-438079-alone group was included. H9c2 cardiomyocytes were transfected with control siRNA or P2rx7 (P2X7) siRNA and stimulated with ATP (5 mM, 24 h). a MitoTracker staining showing mitochondrial networks under the indicated NRCM treatments. b, c Quantification of mitochondrial network metrics in NRCMs: footprint (µm 2 ) ( b ) and individuals ( c ). d Representative MitoSOX staining (with DAPI) visualizing mitochondrial superoxide in NRCMs. e MitoSOX mean fluorescence intensity (MFI) in NRCMs (n = 6). f Representative DCFH-DA fluorescence images of intracellular ROS (green) with DAPI nuclear counterstain (blue) in H9c2 cardiomyocytes. g Quantification of DCFH-DA mean fluorescence intensity in H9c2 cardiomyocytes (MFI, fold to Control) (n = 3). h-j Oxidative-stress markers in NRCMs: 4-hydroxynonenal (4-HNE) ( h ), 8-OHdG ( i ), catalase (CAT) ( j ) (n = 4). l Western blots of key antioxidant enzymes (CAT, GPX4, SOD2) in H9c2 cells under siRNA treatments. l – o Cytotoxicity/pyroptosis readouts in NRCMs subjected to the pharmacologic protocol: LDH release ( l ), caspase-1 activity ( m ), and IL-1β ( n ) and IL-18 ( o ) in supernatants (n = 4). One-way ANOVA with Tukey’s post hoc was performed for statistical analysis. Data is presented as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: Proteins were detected with the following primary antibodies: P2X7 (11144–1-AP, Proteintech, Rosemont, IL, USA); NLRP3 (30109–1-AP, Proteintech, Rosemont, IL, USA); apoptosis-associated speck-like protein containing a CARD (ASC) (30641–1-AP, Proteintech, Rosemont, IL, USA); Cleaved-Caspase1 (89332, Cell Signaling Technology, Danvers, MA, USA); Caspase1 (83383, Cell Signaling Technology, Danvers, MA, USA); catalase (CAT) (21260–1-AP, Proteintech, Rosemont, IL, USA); glutathione peroxidase 4 (GPX4) (67763–1-Ig, Proteintech, Rosemont, IL, USA); superoxide dismutase 2, mitochondrial (SOD2) (24127–1-AP, Proteintech, Rosemont, IL, USA).

Techniques: Inhibition, In Vitro, Transfection, Control, Staining, Fluorescence, Western Blot, Activity Assay

Pharmacological inhibition of P2X7 by A438079 improves HFpEF phenotypes. a Schematic of the experimental design. After 3-hit HFpEF induction, mice received A438079 (5 mg/kg, via osmotic pump) or vehicle for two weeks. b WGA staining of myocardial sections showing cross-sectional area of cardiomyocytes, quantified on the right. c Masson’s trichrome staining to evaluate myocardial fibrosis, with fibrosis percentage shown on the right. d mRNA expression of Col1a2, Timp1, Fn1, and α-SMA in hearts. e Representative H&E staining of heart sections. f Representative images of CD31 immunohistochemical staining in heart sections. g Serum NT-proBNP. h Heart weight normalized to tibia length (HW/TL). i Treadmill running distance for exercise capacity. j Left ventricular ejection fraction measured by echocardiography. k Ratio of early Doppler transmitral flow velocity (E) to tissue Doppler velocity (e′). One-way ANOVA with Tukey’s post hoc was performed for statistical analysis. n = 6 mice/group. Data is presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Basic Research in Cardiology

Article Title: Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis

doi: 10.1007/s00395-025-01138-5

Figure Lengend Snippet: Pharmacological inhibition of P2X7 by A438079 improves HFpEF phenotypes. a Schematic of the experimental design. After 3-hit HFpEF induction, mice received A438079 (5 mg/kg, via osmotic pump) or vehicle for two weeks. b WGA staining of myocardial sections showing cross-sectional area of cardiomyocytes, quantified on the right. c Masson’s trichrome staining to evaluate myocardial fibrosis, with fibrosis percentage shown on the right. d mRNA expression of Col1a2, Timp1, Fn1, and α-SMA in hearts. e Representative H&E staining of heart sections. f Representative images of CD31 immunohistochemical staining in heart sections. g Serum NT-proBNP. h Heart weight normalized to tibia length (HW/TL). i Treadmill running distance for exercise capacity. j Left ventricular ejection fraction measured by echocardiography. k Ratio of early Doppler transmitral flow velocity (E) to tissue Doppler velocity (e′). One-way ANOVA with Tukey’s post hoc was performed for statistical analysis. n = 6 mice/group. Data is presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: Proteins were detected with the following primary antibodies: P2X7 (11144–1-AP, Proteintech, Rosemont, IL, USA); NLRP3 (30109–1-AP, Proteintech, Rosemont, IL, USA); apoptosis-associated speck-like protein containing a CARD (ASC) (30641–1-AP, Proteintech, Rosemont, IL, USA); Cleaved-Caspase1 (89332, Cell Signaling Technology, Danvers, MA, USA); Caspase1 (83383, Cell Signaling Technology, Danvers, MA, USA); catalase (CAT) (21260–1-AP, Proteintech, Rosemont, IL, USA); glutathione peroxidase 4 (GPX4) (67763–1-Ig, Proteintech, Rosemont, IL, USA); superoxide dismutase 2, mitochondrial (SOD2) (24127–1-AP, Proteintech, Rosemont, IL, USA).

Techniques: Inhibition, Staining, Expressing, Immunohistochemical staining

List of primary antibodies and pharmacological compounds.

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet: List of primary antibodies and pharmacological compounds.

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques:

Immunohistochemical labeling and snRNA sequencing analysis showing P2X7R expression in the human cervical spinal cord. All snRNA sequencing data was collected and previously analyzed by Gautier et al., 2023. Alpha and gamma motor neuron clusters were identified by authors based on the enrichment of known marker genes from the mouse. All plots show normalized expression data. (A) Human cervical spinal cord sections showing P2X7R expression co-localized to ChAT+ MN in the ventral horn. White arrows indicate representative spinal MN that are enlarged in the lower panel. Scale bar = 50µM. (B) Mouse cervical spinal cord sections showing a similar expression pattern as observed in human with P2X7R co-localizing with ChAT+ MN in the ventral horn. (C and D) Feature plot showing expression of P2RX7 and P2RX4 in alpha and gamma motor neuron clusters from snRNA sequencing data from the human cervical spinal cord. (E and F) Ridge plots comparing P2RX7 and P2RX4 gene expression in alpha and gamma motor neurons highlighting alpha motor neurons with greater P2RX7 expression compared to gamma neurons. (G and H) Violin plots showing the distribution of motor neurons that express P2RX7 and those that express P2RX4. (I) Feature plots comparing normalized expression of all P2RX genes in human motor neurons showing that P2RX7 is expressed more strongly and in a greater proportion of motor neurons compared to all other P2RX receptors.

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet: Immunohistochemical labeling and snRNA sequencing analysis showing P2X7R expression in the human cervical spinal cord. All snRNA sequencing data was collected and previously analyzed by Gautier et al., 2023. Alpha and gamma motor neuron clusters were identified by authors based on the enrichment of known marker genes from the mouse. All plots show normalized expression data. (A) Human cervical spinal cord sections showing P2X7R expression co-localized to ChAT+ MN in the ventral horn. White arrows indicate representative spinal MN that are enlarged in the lower panel. Scale bar = 50µM. (B) Mouse cervical spinal cord sections showing a similar expression pattern as observed in human with P2X7R co-localizing with ChAT+ MN in the ventral horn. (C and D) Feature plot showing expression of P2RX7 and P2RX4 in alpha and gamma motor neuron clusters from snRNA sequencing data from the human cervical spinal cord. (E and F) Ridge plots comparing P2RX7 and P2RX4 gene expression in alpha and gamma motor neurons highlighting alpha motor neurons with greater P2RX7 expression compared to gamma neurons. (G and H) Violin plots showing the distribution of motor neurons that express P2RX7 and those that express P2RX4. (I) Feature plots comparing normalized expression of all P2RX genes in human motor neurons showing that P2RX7 is expressed more strongly and in a greater proportion of motor neurons compared to all other P2RX receptors.

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques: Immunohistochemical staining, Labeling, Sequencing, Analysis, Expressing, Marker, Gene Expression, Immunofluorescence, Single Cell RNA-Seq

P2X7R expression on spinal hiPSC-MN with intracellular compared to extracellular epitope-directed antibodies. (A) Graphical depiction of the differentiation protocol used to generate spinal motor neurons from hiPSC. (B) Immunohistochemical labeling of spinal hiPSC-MN with P2X7R antibodies directed to either an intracellular or extracellular portion of P2X7R showing differential staining patterns. Scale bar = 20 µm. (C) Confocal imaging comparing extracellular and intracellular epitope-directed P2X7R antibodies relative to DiI-labeled membranes on hiPSC-MN. (D) Confocal 3D rendering of CM-DiI labeled hiPSC-MN showing colocalization of P2X7R (extracellular epitope) with DiI-positive areas on the cell body (white arrow) and the neurites. Scale bar = 50 µm. Detail of confocal imaging showing co-localization of punctate P2X7R (extracellular epitope) expression along hiPSC-MN neurites. (E) Western blots showing P2X7R expression in hiPSC-MN, hiPSC-spinal astrocytes. Samples 1-4 represent distinct hiPSC lines from control subjects. (F) The membrane protein fraction of hiPSC-MN after streptavidin-biotin pulldown contains P2X7R (marked by extracellular P2X7R antibody) and membrane N-Cadherin but not cytoplasmic GAPDH. Each band represents a separate protein sample from the CS8PAA hiPSC line. (G) P2X7R expression in human cervical spinal cord (CSC), human brain and mouse cervical spinal cord. All western blots were conducted using the intracellular epitope-directed P2X7R antibody.

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet: P2X7R expression on spinal hiPSC-MN with intracellular compared to extracellular epitope-directed antibodies. (A) Graphical depiction of the differentiation protocol used to generate spinal motor neurons from hiPSC. (B) Immunohistochemical labeling of spinal hiPSC-MN with P2X7R antibodies directed to either an intracellular or extracellular portion of P2X7R showing differential staining patterns. Scale bar = 20 µm. (C) Confocal imaging comparing extracellular and intracellular epitope-directed P2X7R antibodies relative to DiI-labeled membranes on hiPSC-MN. (D) Confocal 3D rendering of CM-DiI labeled hiPSC-MN showing colocalization of P2X7R (extracellular epitope) with DiI-positive areas on the cell body (white arrow) and the neurites. Scale bar = 50 µm. Detail of confocal imaging showing co-localization of punctate P2X7R (extracellular epitope) expression along hiPSC-MN neurites. (E) Western blots showing P2X7R expression in hiPSC-MN, hiPSC-spinal astrocytes. Samples 1-4 represent distinct hiPSC lines from control subjects. (F) The membrane protein fraction of hiPSC-MN after streptavidin-biotin pulldown contains P2X7R (marked by extracellular P2X7R antibody) and membrane N-Cadherin but not cytoplasmic GAPDH. Each band represents a separate protein sample from the CS8PAA hiPSC line. (G) P2X7R expression in human cervical spinal cord (CSC), human brain and mouse cervical spinal cord. All western blots were conducted using the intracellular epitope-directed P2X7R antibody.

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques: Expressing, Immunohistochemical staining, Labeling, Staining, Confocal, Imaging, Western Blot, Control, Membrane, Immunofluorescence

Treatment of control hiPSC-MN with BzATP leads to P2X7R-mediated calcium influx blocked by JNJ-5567. (A) Colorimetric image showing the change in Fura-2 AM ratio following the application of 300 µM of BzATP compared to vehicle. Scale bar = 20 µm. (B) Fura-2 AM signal in response to 300 µM of BzATP following prior incubation in either 3 µM or 300 nM of JNJ-5567 showing a reduction in calcium influx that is dependent on the concentration of JNJ-5567. (C) Representative Fura-2 AM signals from 3 technical replicates from a single hiPSC-MN cell line treated with 300 µM of BzATP showing a stereotypic response. (D) Quantification of the maximum change in intracellular calcium following BzATP application for the experiments shown in (B). Significance values indicate ** P < 0.01, * ** P < 0.001, n = 3 biological replicates (cell lines CS8PAA, CS9XH7, CS0002) and n = 3 technical replicates per condition.

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet: Treatment of control hiPSC-MN with BzATP leads to P2X7R-mediated calcium influx blocked by JNJ-5567. (A) Colorimetric image showing the change in Fura-2 AM ratio following the application of 300 µM of BzATP compared to vehicle. Scale bar = 20 µm. (B) Fura-2 AM signal in response to 300 µM of BzATP following prior incubation in either 3 µM or 300 nM of JNJ-5567 showing a reduction in calcium influx that is dependent on the concentration of JNJ-5567. (C) Representative Fura-2 AM signals from 3 technical replicates from a single hiPSC-MN cell line treated with 300 µM of BzATP showing a stereotypic response. (D) Quantification of the maximum change in intracellular calcium following BzATP application for the experiments shown in (B). Significance values indicate ** P < 0.01, * ** P < 0.001, n = 3 biological replicates (cell lines CS8PAA, CS9XH7, CS0002) and n = 3 technical replicates per condition.

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques: Control, Incubation, Concentration Assay, Calcium Imaging

Treatment of control hiPSC-MN with BzATP leads to P2X7R-mediated, dose dependent, caspase-mediated, motor neuron loss rescued by by JNJ-5567. (A) Immunocytochemistry and motor motor neuron quantification showing survival of hiPSC-MN treated with BzATP for 2 weeks. (B) The P2X7R antagonist JNJ-5567 provides neuroprotection of hiPSC-MN following BzATP incubation. Scale bar = 50 µm. (C) Neurotoxicity by BzATP and neuroprotection by JNJ-5567 were confirmed using alamarBlue (resazurin) assay, where fluorescence and absorbance of treated and untreated conditions where compared to vehicle condition. (D) Western blot results showing increased caspase 3 expression in hiPSC-MN treated for 2 hours in 1 mM of BzATP which could be reduced with prior incubation in 3 µM of JNJ-5567. Significance values indicate * P < .05, ** P < .01, *** P < .001, **** P < .0001. For (A) and (B) n = 4 biological replicates represented as different shaped data points, and n = 3 technical replicates per condition. For (C), a single cell line (CS8PAA) and n = 12 technical replicates were used.

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet: Treatment of control hiPSC-MN with BzATP leads to P2X7R-mediated, dose dependent, caspase-mediated, motor neuron loss rescued by by JNJ-5567. (A) Immunocytochemistry and motor motor neuron quantification showing survival of hiPSC-MN treated with BzATP for 2 weeks. (B) The P2X7R antagonist JNJ-5567 provides neuroprotection of hiPSC-MN following BzATP incubation. Scale bar = 50 µm. (C) Neurotoxicity by BzATP and neuroprotection by JNJ-5567 were confirmed using alamarBlue (resazurin) assay, where fluorescence and absorbance of treated and untreated conditions where compared to vehicle condition. (D) Western blot results showing increased caspase 3 expression in hiPSC-MN treated for 2 hours in 1 mM of BzATP which could be reduced with prior incubation in 3 µM of JNJ-5567. Significance values indicate * P < .05, ** P < .01, *** P < .001, **** P < .0001. For (A) and (B) n = 4 biological replicates represented as different shaped data points, and n = 3 technical replicates per condition. For (C), a single cell line (CS8PAA) and n = 12 technical replicates were used.

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques: Control, Immunocytochemistry, Incubation, Resazurin Assay, Fluorescence, Western Blot, Expressing, Single Cell, Immunofluorescence

Journal: Stem Cells Translational Medicine

Article Title: Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

doi: 10.1093/stcltm/szae074

Figure Lengend Snippet:

Article Snippet: P2X7R extracellular epitope , Rabbit , 1:100 , 1:100 , Alomone Labs (#APR008).

Techniques:

Cathelicidin-Mediated Inhibition of Colon Cancer Cell Migration Was P2RX7 Dependent (A) SW620 cells were transfected with control lentivirus or TUBB3-overexpressing lentivirus, followed by exposure to LL-37. Cell migration of SW620 cells. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 siRNA (80 pmol/mL), followed by exposure to LL-37. TUBB3 mRNA expression. (C) CAMP, (D) FPRL1, and (E) P2RX7 mRNA expression in human colon cancer PCR array plate. (F) Cell migration of SW620 cells. SW620 cells were treated with DMSO, KN62, and WRW4 for 30 min, followed by LL-37 for 7 h. Results were pooled from three independent experiments.

Journal: Molecular Therapy Oncolytics

Article Title: Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

doi: 10.1016/j.omto.2019.01.004

Figure Lengend Snippet: Cathelicidin-Mediated Inhibition of Colon Cancer Cell Migration Was P2RX7 Dependent (A) SW620 cells were transfected with control lentivirus or TUBB3-overexpressing lentivirus, followed by exposure to LL-37. Cell migration of SW620 cells. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 siRNA (80 pmol/mL), followed by exposure to LL-37. TUBB3 mRNA expression. (C) CAMP, (D) FPRL1, and (E) P2RX7 mRNA expression in human colon cancer PCR array plate. (F) Cell migration of SW620 cells. SW620 cells were treated with DMSO, KN62, and WRW4 for 30 min, followed by LL-37 for 7 h. Results were pooled from three independent experiments.

Article Snippet: Human P2RX7 , Hs00175721_m1.

Techniques: Inhibition, Migration, Transfection, Control, Small Interfering RNA, Expressing

Cathelicidin Inhibited TUBB3 Expression via P2RX7 (A) Green tubulin tracker staining with blue nuclear staining in human cancer SW620 cells. SW620 cells were pretreated with DMSO (10 μL/mL) or KN62 (10 μM) for 30 min, followed by exposure to LL-37 (5 μM) for 24 h. LL-37 reduced tubulin expression in SW620 cells that was prevented by KN62. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 shRNA (1 μg/mL), followed by exposure to LL-37. TUBB3 mRNA expression in SW620 cells. (C) P2RX7 mRNA expression in the transfected SW620 cells. (D) HT-29 cells were pretreated with DMSO (10 μL/mL) or KN62 (10 μM) for 30 min, followed by exposure to LL-37. TUBB3 mRNA expression. Results were pooled from three independent experiments.

Journal: Molecular Therapy Oncolytics

Article Title: Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

doi: 10.1016/j.omto.2019.01.004

Figure Lengend Snippet: Cathelicidin Inhibited TUBB3 Expression via P2RX7 (A) Green tubulin tracker staining with blue nuclear staining in human cancer SW620 cells. SW620 cells were pretreated with DMSO (10 μL/mL) or KN62 (10 μM) for 30 min, followed by exposure to LL-37 (5 μM) for 24 h. LL-37 reduced tubulin expression in SW620 cells that was prevented by KN62. (B) SW620 cells were transiently transfected with control small interfering RNA (siRNA) or P2RX7 shRNA (1 μg/mL), followed by exposure to LL-37. TUBB3 mRNA expression in SW620 cells. (C) P2RX7 mRNA expression in the transfected SW620 cells. (D) HT-29 cells were pretreated with DMSO (10 μL/mL) or KN62 (10 μM) for 30 min, followed by exposure to LL-37. TUBB3 mRNA expression. Results were pooled from three independent experiments.

Article Snippet: Human P2RX7 , Hs00175721_m1.

Techniques: Expressing, Staining, Transfection, Control, Small Interfering RNA, shRNA

Cathelicidin Inhibited Colon Cancer Metastasis via P2RX7 (A and B) Human cytokeratin-18 expression (representing human colon cancer cells) in (A) lungs and (B) liver of nude mice was identified by brown color spots (indicated by arrows). Intravenous cathelicidin expressing AAV administration reduced human CK18 expression in lungs and liver of nude mice.

Journal: Molecular Therapy Oncolytics

Article Title: Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

doi: 10.1016/j.omto.2019.01.004

Figure Lengend Snippet: Cathelicidin Inhibited Colon Cancer Metastasis via P2RX7 (A and B) Human cytokeratin-18 expression (representing human colon cancer cells) in (A) lungs and (B) liver of nude mice was identified by brown color spots (indicated by arrows). Intravenous cathelicidin expressing AAV administration reduced human CK18 expression in lungs and liver of nude mice.

Article Snippet: Human P2RX7 , Hs00175721_m1.

Techniques: Expressing

Cathelicidin Inhibited TUBB3 mRNA Expression in Metastasized Tumors via P2RX7 (A and B) Human keratin 20 mRNA expression (human colon cancer cell marker) in (A) lungs and (B) liver of nude mice was significantly reduced by CAMP -HA-AAV. Intraperitoneal KN62 treatment increased the presence of cytokeratin 18 protein and keratin 20 mRNA expression in the CAMP -HA-AAV-treated nude mice. (C and D) Human TUBB3 mRNA expression in (C) lungs and (D) liver of nude mice was significantly reduced by CAMP -HA-AAV. Intraperitoneal KN62 treatment increased the presence of human TUBB3 mRNA expression in the CAMP -HA-AAV-treated nude mice. (E) Diameters of subcutaneous tumors. Intravenous CAMP -HA-AAV significantly reduced subcutaneous tumor diameters in nude mice that were partially reversed by KN62 treatment.

Journal: Molecular Therapy Oncolytics

Article Title: Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

doi: 10.1016/j.omto.2019.01.004

Figure Lengend Snippet: Cathelicidin Inhibited TUBB3 mRNA Expression in Metastasized Tumors via P2RX7 (A and B) Human keratin 20 mRNA expression (human colon cancer cell marker) in (A) lungs and (B) liver of nude mice was significantly reduced by CAMP -HA-AAV. Intraperitoneal KN62 treatment increased the presence of cytokeratin 18 protein and keratin 20 mRNA expression in the CAMP -HA-AAV-treated nude mice. (C and D) Human TUBB3 mRNA expression in (C) lungs and (D) liver of nude mice was significantly reduced by CAMP -HA-AAV. Intraperitoneal KN62 treatment increased the presence of human TUBB3 mRNA expression in the CAMP -HA-AAV-treated nude mice. (E) Diameters of subcutaneous tumors. Intravenous CAMP -HA-AAV significantly reduced subcutaneous tumor diameters in nude mice that were partially reversed by KN62 treatment.

Article Snippet: Human P2RX7 , Hs00175721_m1.

Techniques: Expressing, Marker

Primers for Real-Time RT-PCR

Journal: Molecular Therapy Oncolytics

Article Title: Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism

doi: 10.1016/j.omto.2019.01.004

Figure Lengend Snippet: Primers for Real-Time RT-PCR

Article Snippet: Human P2RX7 , Hs00175721_m1.

Techniques: